MRSA News

The FDA has expanded the indication for Teflaro, an injectable antibiotic in the cephalosporin class, to treat pediatric patients aged 2 months to 18 years with community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections, including MRSA.

Antibiotic susceptibility trends suggested that the prevalence of Staphylococcus aureus infections caused by MRSA among children has declined during the last decade, according to recent research in Pediatrics.

Despite continuing reductions in the overall incidence of health care-associated infections, or HAIs, antibiotic resistant bacteria continue to be responsible for a substantial portion of these nosocomial infections, according to data recently published in MMWR.

Methicillin-susceptible Staphylococcus aureus caused more infections and deaths in a neonatal intensive care unit than MRSA, while both strains were found to have similar mortality rates after infection in a recent study.

Surgical site infections in pediatric patients who underwent spine surgery were most likely to be caused by Staphyloccocus aureus, gram-negative bacilli and gram positive anaerobe cocci, according to a recent study.

The FDA has granted a qualified infectious disease product designation to an investigational fusidic acid antibiotic for the prevention of acute bacterial skin and skin structure infections.

Staphylococcus aureus bacteria colonize the nasopharynx almost immediately after birth, but decline rapidly as other respiratory bacterial pathogens are introduced, according to recent study data.

Results from a multicenter, prospective, randomized double blind clinical trial indicate clindamycin and trimethoprim-sulfamethoxazole have comparable efficacy and safety for treatment of uncomplicated skin infections.

MEMPHIS, Tenn. — While mortality remained higher for infants with methicillin-resistant Staphylococcus aureus infections, there were more invasive methicillin-sensitive S. aureus infections and a greater absolute number of deaths after this infection, according to data presented at the St. Jude/PIDS Pediatric Infectious Diseases Research Conference.

Acute kidney injury was common among hospitalized children who received vancomycin, with higher doses associated with an increased risk for kidney damage, according to study data.